Skip to main content

letter

. 2013 Apr 3;34(1):55. [Article in Spanish] doi: 10.1016/S0212-6567(04)79452-4

Utilidad terapéutica de un efecto secundario para el control de la sialorrea

A Palau Galindo ¹, M Ciutat Benet ¹, A Fernández González ¹, M Planellas Boix ¹

PMCID: PMC7688675 PMID: 15207202

The content is available as a PDF (59.8 KB).

Bibliografía

1.Definition of Drooling [consultado 2/4/2003]. Disponible http://www.droolin-ginfo.org/index.html
2.Thomas A. Salzer MD. Sialorrea 5 [consultado 4/1/2001]. Disponible http://www.bcm.tmc.edu/oto/grand/100591.html
3.Lew K., Younis R., Lazar R. The current management of Sialorrea. Ear Nose Throat J. 1991;70:99–105. [PubMed] [Google Scholar]
4.Mier R.J., Bachrach S.J., Lakin R.C., Baker T., Childs J., Moran M. Treatment of sialorrea with glycopirrolate: a double-blind, dose-ranging study. Arch Pediatr Adolesc Med. 2000;154:1214–1218. doi: 10.1001/archpedi.154.12.1214. [DOI] [PubMed] [Google Scholar]
5.Dreyfuss P., Vogel D., Walsh N. The use of transdermal scopolamine to control drooling. A case report. Am J Phys Med Rehabil. 1991;70:220–222. doi: 10.1097/00002060-199108000-00012. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES